The fact
No financing announcement has been made, despite investor expectations.
The biopharmaceutical company's stock remains under scrutiny.
Click the link to read an article on the topic:
Why it matters
L'absence de communication sur un financement potentiel pourrait impacter la confiance des investisseurs et la valorisation boursière d'Innate Pharma.